Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Porter, N. Hollenberg (1997)
Obesity, salt intake, and renal perfusion in healthy humans.Hypertension, 32 1
H. Laws, M. Palmer, J. Bryant, A. Boudreaux, A. Wheeler (1986)
Effects of Preoperative Medications on Gastric pH, Volume, and FloraAnnals of Surgery, 203
K. Øvrebø, J. Hatlebakk, Asgaut Viste, Hans Bassøe, Knut Svanes (1998)
Gastroesophageal reflux in morbidly obese patients treated with gastric banding or vertical banded gastroplasty.Annals of surgery, 228 1
O. Wisén, S. Rössner, C. Johansson (1988)
Impaired pancreatico-biliary response to vagal stimulation and to cholecystokinin in human obesity.Metabolism: clinical and experimental, 37 5
D. Verset, J. Houben, F. Gay, J. Elcheroth, V. Bourgeois, A. Gossum (1997)
The Place of Upper Gastrointestinal Tract Endoscopy Before and After Vertical Banded Gastroplasty for Morbid ObesityDigestive Diseases and Sciences, 42
G. Perdichizzi, M. Bottari, S. Pallio, M. Fera, M. Carbone, G. Barresi (1996)
Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects.The new microbiologica, 19 2
I. Benedek, R. Blouin, P. McNamara (1984)
Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects.British journal of clinical pharmacology, 18 6
Castell Do (1978)
Medical measures that influence the gastroesophageal junction.Southern Medical Journal
Mercer Cd, S. Wren, L. Dacosta, I. Beck (1988)
Lower esophageal sphincter pressure and gastroesophageal pressure gradients in excessively obese patients.Journal of medicine, 18 3-4
Robert Blouin, J. Kolpek, H. Mann (1987)
Influence of obesity on drug disposition.Clinical pharmacy, 6 9
O. Wisén, C. Johansson (1992)
Gastrointestinal function in obesity: motility, secretion, and absorption following a liquid test meal.Metabolism: clinical and experimental, 41 4
E. Gonzalez (1990)
Pharmacokinetics of ranitidine in morbidly obese women.Dicp-The annals of pharmacotherapy, 24
A. Lam, D. Grace, F. Penny, W. Vezina (1986)
Prophylactic intravenous cimetidine reduces the risk of acid aspiration in morbidly obese patients.Anesthesiology, 65 6
J. Labenz, P. Malfertheiner (1997)
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?Gut, 41
(1987)
Gastric secretion in massive obesity. Evidence for abnormal response to vagal stimulation
I. Benedek, W. Fiske, W. Griffen, R. Bell, R. Blouin, P. McNamara (1983)
Serum alpha 1-acid glycoprotein and the binding of drugs in obesity.British journal of clinical pharmacology, 16 6
D. Abernethy, D. Greenblatt (1986)
Drug Disposition in Obese HumansClinical Pharmacokinetics, 11
J. Lagergren, R. Bergström, O. Nyrén (2000)
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based studyGut, 47
K. Jones (1998)
Roux-en-Y Gastric Bypass: An Effective Antireflux Procedure in the Less Than Morbidly ObeseObesity Surgery, 8
S. Frank, J. Colliver, A. Frank (1986)
The electrocardiogram in obesity: statistical analysis of 1,029 patients.Journal of the American College of Cardiology, 7 2
G. Cheymol (1988)
DRUG PHARMACOKINETICS IN THE OBESE *Fundamental & Clinical Pharmacology, 2
F. Cibella, G. Cuttitta, S. Romano, V. Bellia, G. Bonsignore (1997)
Evaluation of diaphragmatic fatigue in obstructive sleep apnoeas during non-REM sleep.Thorax, 52
G. Locke, N. Talley, S. Fett, A. Zinsmeister, L. Melton (1999)
Risk factors associated with symptoms of gastroesophageal reflux.The American journal of medicine, 106 6
Y. Romero, A. Cameron, G. Locke, D. Schaid, J. Slezak, C. Branch, L. Melton (1997)
Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma.Gastroenterology, 113 5
R. Blouin, G. Warren (1999)
Pharmacokinetic considerations in obesity.Journal of pharmaceutical sciences, 88 1
Zuo‐Feng Zhang, R. Kurtz, Guo-Pei Yu, Ming Sun, N. Gargon, M. Karpeh, Jeffrey Fein, S. Harlap (1997)
Adenocarcinomas of the esophagus and gastric cardia: the role of diet.Nutrition and cancer, 27 3
J. Isolauri, P. Laippala (1995)
Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population.Annals of medicine, 27 1
R. Harter, W. Kelly, Matthew Kramer, Cara Perez, R. Dzwonczyk (1998)
A Comparison of the Volume and pH of Gastric Contents of Obese and Lean Surgical PatientsAnesthesia & Analgesia, 86
O’connor (1999)
Review article: Helicobacter pylori and gastro‐oesophageal reflux disease—clinical implications and managementAlimentary Pharmacology & Therapeutics, 13
(1994)
Cost of digestive disease in the United States
(1994)
Lean body mass as a predictor of drug dosage. Implications for drug therapy
F. Murray, J. Ennis, J. Lennon, J. Crowe (1991)
Management of reflux oesophagitis: Role of weight loss and cimetidineIrish Journal of Medical Science, 160
D. Salazar, C. Sorge, G. Corcoran (1988)
Obesity as a risk factor for drug-induced organ injury. VI. Increased hepatic P450 concentration and microsomal ethanol oxidizing activity in the obese overfed rat.Biochemical and biophysical research communications, 157 1
(1998)
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.Obesity research, 6 Suppl 2
R. Schmieder, A. Beil, H. Weihprecht, F. Messerli (1995)
How should renal hemodynamic data be indexed in obesity?Journal of the American Society of Nephrology : JASN, 5 9
D. Abernethy, D. Greenblatt, R. Matlis, R. Gugler (1984)
Cimetidine disposition in obesity.The American journal of gastroenterology, 79 2
T. Demeester, J. Peters, C. Bremner, Parakh Chandrasoma (1999)
Biology of gastroesophageal reflux disease: pathophysiology relating to medical and surgical treatment.Annual review of medicine, 50
H. Sugerman, E. DeMaria, W. Felton, M. Nakatsuka, A. Sismanis (1997)
Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebriNeurology, 49
G. Cheymol (1993)
Clinical Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 25
M. Takemoto, H. Morishita, K. Higuchi, J. Yoshida, T. Aono (1994)
Effects of body weight on responses of serum prolactin to metoclopramide and thyrotrophin-releasing hormone in secondary amenorrhoeic women.Human reproduction, 9 5
T. O'Brien (1980)
Lower Esophageal Sphincter Pressure (LESP) and Esophageal Function in Obese HumansJournal of Clinical Gastroenterology, 2
R. Snider, J. Kruse, J. Bander, G. Dunn (1995)
Accuracy of Estimated Creatinine Clearance in Obese Patients With Stable Renal Function in the Intensive Care UnitPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 15
J. Henney (2000)
Withdrawal of Troglitazone and CisaprideJAMA, 283
A. Kjellin, S. Ramel, S. Rössner, Kjell Thor (1996)
Gastroesophageal reflux in obese patients is not reduced by weight reduction.Scandinavian journal of gastroenterology, 31 11
K. Seymour, A. Mackie, E. McCauley, J. Stephen (1998)
Changes in Esophageal Function after Vertical Banded Gastroplasty as Demonstrated by Esophageal ScintigraphyObesity Surgery, 8
G. Stene-Larsen, R. Weberg, I. Larsen, O. Bjørtuft, B. Hoel, A. Berstad (1988)
Relationship of overweight to hiatus hernia and reflux oesophagitis.Scandinavian journal of gastroenterology, 23 4
(1998)
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence reportObes Res, 6
Sven Röjdmark, Stephan Rössner (1991)
Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting.Metabolism: clinical and experimental, 40 2
C. Ruhl, J. Everhart (1999)
Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey.Annals of epidemiology, 9 7
Chi-Sen Chang, Poon Sk, H. Lien, Chen Gh (1997)
The incidence of reflux esophagitis among the Chinese.The American journal of gastroenterology, 92 4
Sherman Smith, Charles Edwards, G. Goodman (1997)
Symptomatic and Clinical Improvement in Morbidly Obese Patients with Gastroesophageal Reflux Disease Following Roux-en-Y Gastric BypassObesity Surgery, 7
S. Devesa, W. Blot, J. Fraumeni (1998)
Changing patterns in the incidence of esophageal and gastric carcinoma in the United StatesCancer, 83
M. Deitel, R. Khanna, J. Hagen, R. Ilves (1988)
Vertical banded gastroplasty as an antireflux procedure.American journal of surgery, 155 3
J. Richter (1999)
Do we know the cause of reflux disease?European journal of gastroenterology & hepatology, 11 Suppl 1
D. Farrow, D. Farrow, T. Vaughan, C. Sweeney, M. Gammon, W. Chow, H. Risch, J. Stanford, P. Hansten, S. Mayne, J. Schoenberg, H. Rotterdam, H. Ahsan, A. West, R. Dubrow, J. Fraumeni, W. Blot (2000)
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancerCancer Causes & Control, 11
Gastro‐oesophageal reflux disease (GERD) is common in obese patients. Apart from the physical discomfort and the economic burden, GERD may increase morbidity and mortality through its association with oesophageal carcinoma. The pathophysiology of GERD differs between obese and lean subjects. First, obese subjects are more sensitive to the presence of acid in the oesophagus. Second, hiatal hernia, capable of promoting GERD by several mechanisms, is more prevalent among the obese. Third, obese subjects have increased intra‐abdominal pressure that displaces the lower oesophageal sphincter and increases the gastro‐oesophageal gradient. Finally, vagal abnormalities associated with obesity may cause a higher output of bile and pancreatic enzymes, which makes the refluxate more toxic to the oesophageal mucosa. The altered body composition associated with obesity affects the pharmacokinetics of drugs. There are no data regarding the efficacy of any of the drugs used for GERD treatment. The dosages of cimetidine and ranitidine should be calculated according to the patient’s ideal body weight, not their actual weight. Of the operative procedures used for weight loss, Roux‐en‐Y gastric bypass was found to be most effective for GERD, while gastric banding was associated with a high prevalence of reflux. This review outlines the pathophysiology and the treatment of GERD in obesity with emphasis on the therapeutic considerations in this population of patients.
Obesity Reviews – Wiley
Published: Feb 1, 2002
Keywords: ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.